IP Library Granted Patent US 11,981,947
Granted Patent B2
US 11,981,947 · App. 17/814,333 · Granted May 14, 2024

Production of oligosaccharides

Inventor: Stefan Jennewein (Bad Honnef, DE)
Assignee: Chr. Hansen HMO GmbH
C12P19/26C07H1/00C07H1/06C12N1/205C12N15/72C12P19/00C12P19/12C12P19/14C12Y302/01C12Y302/01023C12N2800/101C12R2001/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,981,947
App. No.
17/814,333
Granted
May 14, 2024
Kind
B2
Abstract

The present invention relates to the use of one or more glycosidases in the process for the production and/or purification of a produced desired oligosaccharide. The process is preferably a microbial fermentation process using a host microorganism, which may also comprise nucleic acids expressing sugar catabolic pathway proteins suitable for the degradation of saccharides otherwise hindering the purification of the desired oligosaccharide.

Claims (22)

1. A process for producing a desired oligosaccharide in a host microorganism, wherein the desired oligosaccharide is not naturally occurring in said host microorganism, the process comprising the steps of:

a) cultivating the host microorganism that produces the desired oligosaccharide under conditions and in a fermentation medium suitable for the production of the desired oligosaccharide, thereby producing the desired oligosaccharide and undesired biosynthetic saccharide intermediates, wherein the desired oligosaccharide is a human milk oligosaccharide selected from the group consisting of 3-Fucosyllactose, 2′3-Difucosyllactose, 3′-Sialyllactose, 6′-Sialyllactose, 3-Fucosyl-3′-sialyllactose, Lacto-N-tetraose, Lacto-N-neotetraose, Lacto-N-fucopentaose I, Lacto-N-fucopentaose II, Lacto-N-fucopentaose III, Lacto-N-fucopentaose V, Lacto-N-difucosylhexaose I, Lacto-N-difucosylhexaose II, Lacto-N-sialylpentaose LSTa, LSTb, LSTc, Lacto-N-triose II, Lacto-N-neofucopentaose I, Lacto-N-neofucopentaose V, 6′-Galactosyllactose, 3′-Galactosyllactose, Lacto-N-hexaose, Lacto-N-neohexaose, para-Lacto-N-hexaose, para-Lacto-N-neohexaose, Difucosyl-lacto-N-neohexaose, Fucosyl-lacto-N-sialylpentaose a, Fucosyl-lacto-N-sialylpentaose b, Fucosyl-lacto-N-sialylpentaose c, Disialyl-lacto-N-tetraose, Disialyl-lacto-N-fucopentaose, 3-Fucosyl-6′-sialyllactose, Lacto-N-neodifucohexaose I;

b) directly adding an exogenous beta-galactosidase enzyme to the fermentation medium at the end of the cultivation of a) to degrade unused saccharide substrates and/or undesired biosynthetic saccharide intermediates and/or saccharide side products generated during production of the desired oligosaccharide in step a), and

c) recovering the desired oligosaccharide.

2. The process of claim 1 , further comprising centrifuging the cultivated host microorganism to obtain a supernatant and a host microorganism pellet, and recovering the desired oligosaccharide from the supernatant.

3. The process of claim 1 , wherein the host microorganism is a bacterium or a yeast.

4. The process of claim 3 , wherein the host microorganism is an Escherichia coli strain, a Lactobacillus species, a Corynebacterium glutamicum strain, or a Saccharomyces sp. strain.

5. The process of claim 1 , wherein the host microorganism is a wild-type microorganism modified to overexpress proteins for a galactose catabolic pathway under the control of an inducible promoter.

6. A method for purifying a desired oligosaccharide of interest from a mixture containing the desired oligosaccharide and

a) non-desired oligosaccharides or metabolic saccharide products generated during production of the desired oligosaccharide, and/or

b) unused saccharide substrates used in the production of the desired oligosaccharide,

wherein the desired oligosaccharide is a human milk oligosaccharide selected from the group consisting of 3-Fucosyllactose, 2′3-Difucosyllactose, 3′-Sialyllactose, 6′-Sialyllactose, 3-Fucosyl-3′-sialyllactose, Lacto-N-tetraose, Lacto-N-neotetraose, Lacto-N-fucopentaose I, Lacto-N-fucopentaose II, Lacto-N-fucopentaose III, Lacto-N-fucopentaose V, Lacto-N-difucosylhexaose I, Lacto-N-difucosylhexaose II, Lacto-N-sialylpentaose LSTa, LSTb, LSTc, Lacto-N-triose II, Lacto-N-neofucopentaose I, Lacto-N-neofucopentaose V, 6′-Galactosyllactose, 3′-Galactosyllactose, Lacto-N-hexaose, Lacto-N-neohexaose, para-Lacto-N-hexaose, para-Lacto-N-neohexaose, Difucosyl-lacto-N-neohexaose, Fucosyl-lacto-N-sialylpentaose a, Fucosyl-lacto-N-sialylpentaose b, Fucosyl-lacto-N-sialylpentaose c, Disialyl-lacto-N-tetraose, Disialyl-lacto-N-fucopentaose, 3-Fucosyl-6′-sialyllactose, and Lacto-N-neodifucohexaose I,

the method comprising adding beta-galactosidase to the mixture to degrade the non-desired oligosaccharides or metabolic saccharide products or unused substrates; and recovering the desired oligosaccharide from the mixture.

7. The method of claim 6 , wherein the desired oligosaccharide is produced by in vitro oligosaccharide synthesis, by chemical synthesis, or by combinations thereof.

8. The method of claim 6 , wherein the desired oligosaccharide is a non-naturally occurring oligosaccharide in a host microorganism expressing a beta-galactosidase, and wherein the desired oligosaccharide is produced by a microbial fermentation process in the host microorganism.

9. A process for producing a desired oligosaccharide in a host microorganism, wherein the desired oligosaccharide is not naturally occurring in said host microorganism, the process comprising the steps of:

a) cultivating a host microorganism that can produce the desired oligosaccharide under conditions and in a medium suitable for the production of the desired oligosaccharide, thereby producing the desired oligosaccharide and-undesired biosynthetic saccharide intermediates, wherein the desired oligosaccharide is a human milk oligosaccharide selected from the group consisting of 3-Fucosyllactose, 2′3-Di-fucosyllactose, 3′-Sialyllactose, 6′-Sialyllactose, 3-Fucosyl-3′-sialyllactose, Lacto-N-tetraose, Lacto-N-neotetraose, Lacto-N-fucopentaose I, Lacto-N-fucopentaose II, Lacto-N-fucopentaose III, Lacto-N-fucopentaose V, Lacto-N-difucosylhexaose I, Lacto-N-difucosylhexaose II, Lacto-N-sialylpentaose LSTa, LSTb, LSTc, Lacto-N-triose II, Lacto-N-neofucopentaose I, Lacto-N-neofucopentaose V, 6′-Galactosyllactose, 3′-Galactosyllactose, Lacto-N-hexaose, Lacto-N-neohexaose, para-Lacto-N-hexaose, para-Lacto-N-neohexaose, Difucosyl-lacto-N-neohexaose, Fucosyl-lacto-N-sialylpentaose a, Fucosyl-lacto-N-sialylpentaose b, Fucosyl-lacto-N-sialylpentaose c, Disialyl-lacto-N-tetraose, Disialyl-lacto-N-fucopentaose, 3-Fucosyl-6′-sialyllactose, Lacto-N-neodifucohexaose I;

b) externally adding a beta-galactosidase to the medium following production of the desired oligosaccharide in step a) to degrade unused saccharide substrates and/or undesired biosynthetic saccharide intermediates and/or saccharide side products generated during production of the desired oligosaccharide in step a); and

c) recovering the desired oligosaccharide;

wherein the unused saccharide substrate is lactose.

10. The method of claim 1 , wherein the host microorganism does not endogenously produce the beta-galactosidase.

11. The method of claim 9 , wherein the host microorganism does not endogenously produce the beta-galactosidase.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: CHR. HANSEN HMO GMBH
To: CHR. HANSEN A/S
Reel/Frame 070396/0299 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2022
From: JENNEWEIN, STEFAN
To: JENNEWEIN BIOTECHNOLOGIE GMBH
Reel/Frame 061994/0866 →
CHANGE OF NAME Recorded Dec 6, 2022
From: JENNEWEIN BIOTECHNOLOGIE GMBH
To: CHR. HANSEN HMO GMBH
Reel/Frame 062075/0968 →
Priority Claims (1)
EP 13183670 · Sep 10, 2013 · regional
Continuity (3)
Division 15067037 · Mar 10, 2016
Continuation PCTEP2014064280 · Jul 4, 2014
Related Publication 20220389468A1 · Dec 8, 2022